198 related articles for article (PubMed ID: 37735586)
1. Propolis-loaded nanostructured lipid carriers halt breast cancer progression through miRNA-223 related pathways: an in-vitro/in-vivo experiment.
Shaker SA; Alshufta SM; Gowayed MA; El-Salamouni NS; Bassam SM; Megahed MA; El-Tahan RA
Sci Rep; 2023 Sep; 13(1):15752. PubMed ID: 37735586
[TBL] [Abstract][Full Text] [Related]
2. Propolis-Based Nanostructured Lipid Carriers for α-Mangostin Delivery: Formulation, Characterization, and In Vitro Antioxidant Activity Evaluation.
Suhandi C; Wilar G; Lesmana R; Zulhendri F; Suharyani I; Hasan N; Wathoni N
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630309
[TBL] [Abstract][Full Text] [Related]
3. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
4. Design, Evaluation And Antimicrobial Activity Of Egyptian Propolis-Loaded Nanoparticles: Intrinsic Role As A Novel And Naturally Based Root Canal Nanosealer.
Abdel Raheem IA; Abdul Razek A; Elgendy AA; Saleh NM; Shaaban MI; Abd El-Hady FK
Int J Nanomedicine; 2019; 14():8379-8398. PubMed ID: 31695372
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
6. Propolis Enhances 5-Fluorouracil Mediated Antitumor Efficacy and Reduces Side Effects in Colorectal Cancer: An in Vitro and in Vivo Study.
Kocyigit A; Guler EM; Durmus E; Yenigun VB; Kanimdan E; Ozman Z; Yasar O; Goren AC; Hekimoglu ER; Oruc HH; Aydogdu G
Chem Biodivers; 2023 Sep; 20(9):e202300591. PubMed ID: 37497658
[TBL] [Abstract][Full Text] [Related]
7. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
[No Abstract] [Full Text] [Related]
8. Effect of Turkish Propolis on miRNA Expression, Cell Cycle, and Apoptosis in Human Breast Cancer (MCF-7) Cells.
Misir S; Aliyazicioglu Y; Demir S; Turan I; Hepokur C
Nutr Cancer; 2020; 72(1):133-145. PubMed ID: 31112051
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
12. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
13. Inducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer Therapy.
Deng C; Jia M; Wei G; Tan T; Fu Y; Gao H; Sun X; Zhang Q; Gong T; Zhang Z
Mol Pharm; 2017 Jan; 14(1):296-309. PubMed ID: 27936775
[TBL] [Abstract][Full Text] [Related]
14. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
Ghosh S; Pal A; Ray M
Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
[TBL] [Abstract][Full Text] [Related]
15. Propolis Potentiates Methotrexate Anticancer Mechanism and Reduces its Toxic Effects.
Salem MM; Donia T; Abu-Khudir R; Ramadan H; Ali EMM; Mohamed TM
Nutr Cancer; 2020; 72(3):460-480. PubMed ID: 31318622
[TBL] [Abstract][Full Text] [Related]
16. Protective role of Egyptian propolis against tumor in mice.
El-khawaga OA; Salem TA; Elshal MF
Clin Chim Acta; 2003 Dec; 338(1-2):11-6. PubMed ID: 14637260
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumor and renoprotection study of E-[c(RGDfK)
Zhang B; Zhang Y; Dang W; Xing B; Yu C; Guo P; Pi J; Deng X; Qi D; Liu Z
J Nanobiotechnology; 2022 Sep; 20(1):425. PubMed ID: 36153589
[TBL] [Abstract][Full Text] [Related]
19. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
20. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
